Tumor Biology

, Volume 35, Issue 1, pp 419–423 | Cite as

Clinicopathological significance of SLP-2 overexpression in human gallbladder cancer

  • Wei-Xin Wang
  • Qing-Feng Lin
  • Dong Shen
  • Shao-Ping Liu
  • Wei-Dong Mao
  • Gui Ma
  • Wei-Dong Qi
Research Article


Several studies have indicated that overexpression of stomatin-like protein 2 (SLP-2) has been identified in several types of cancer. However, its role and clinical relevance in gallbladder cancer (GBC) is unknown. The purpose of this study was to reveal the prognostic significance of SLP-2 in GBC. The SLP-2 expression was examined at mRNA and protein levels by real-time quantitative polymerase chain reaction (qRT-PCR), and immunohistochemistry in GBC tissues and adjacent noncancerous tissues. Statistical analyses were applied to test the associations between SLP-2 expression, clinicopathologic factors, and prognosis. Immunohistochemistry and qRT-PCR showed that the protein and mRNA expression levels of SLP-2 were both significantly higher in GBC tissues than in adjacent noncancerous tissues. In addition, immunohistochemistry analysis showed that SLP-2 expression was significantly correlated with histological grade (P <0.001), pathologic T stage (P = 0.019), clinical stage (P = 0.001), and lymph node metastasis (P = 0.026). The Kaplan–Meier survival curves indicated that patients with high expression of SLP-2 had shorter overall survival than those with low expression (P <0.001). Meanwhile, the Cox multivariate analysis indicated that high expressions of SLP-2 were an independent prognostic factor for patients with GBC. These data showed that SLP-2 may play an important role in human GBC tumorigenesis, and SLP-2 might serve as a novel prognostic marker in human GBC.


SLP-2 Immunohistochemistry qRT-PCR Prognosis 


Conflicts of interest



  1. 1.
    Manfredi S, Benhamiche AM, Isambert N, Prost P, Jouve JL, Faivre J. Trends in incidence and management of gallbladder carcinoma: a population-based study in France. Cancer. 2000;89:757–62.PubMedCrossRefGoogle Scholar
  2. 2.
    Donohue JH. Present status of the diagnosis and treatment of gallbladder carcinoma. J Hepatobiliary Pancreatol Surg. 2001;8:530–4.CrossRefGoogle Scholar
  3. 3.
    Chen Y, Chen Y, Yu G, Ding H. Lymphangiogenic and angiogentic microvessel density in gallbladder carcinoma. Hepatogastroenterology. 2011;58:20–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Kim WS, Choi DW, You DD, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg. 2010;14:679–87. doi: 10.1007/s11605-009-1140-z.PubMedCrossRefGoogle Scholar
  5. 5.
    Wang Y, Morrow JS. Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem. 2000;275(11):8062–71.PubMedCrossRefGoogle Scholar
  6. 6.
    Cao W, Zhang B, Ding F, Zhang W, Sun B, Liu Z. Expression of SLP-2 was associated with invasion of esophageal squamous cell carcinoma. PLoS One. 2013;8:e63890. doi: 10.1371/journal.pone.0063890.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Zhang L, Ding F, Cao W, Liu Z, Liu W, Yu Z, et al. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res. 2006;12:1639–46. doi: 10.1158/1078-0432.CCR-05-1858.PubMedCrossRefGoogle Scholar
  8. 8.
    Liu D, Zhang L, Shen Z, Tan F, Hu Y, Yu J, Li G. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer. Gastric Cancer. 2013 Jan 31. [Epub ahead of print]Google Scholar
  9. 9.
    Liu LY, Han YC, Wu SH, Lv ZH. Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World J Gastroenterol. 2008;14:2110–4. doi: 10.3748/wjg.14.2110.PubMedCrossRefGoogle Scholar
  10. 10.
    Cao W, Zhang B, Li J, Liu Y, Liu Z, Sun B. SLP-2 overexpression could serve as a prognostic factor in node positive and HER2 negative breast cancer. Pathol. 2011;43:713–8. doi: 10.1097/PAT.0b013e32834c34ed.CrossRefGoogle Scholar
  11. 11.
    Cui Z, Zhang L, Hua Z, Cao W, Feng W, Liu Z. Stomatin-like protein 2 is overexpressed and related to cell growth in human endometrial adenocarcinoma. Oncol Rep. 2007;17:829–33.PubMedGoogle Scholar
  12. 12.
    Cao WF, Zhang LY, Liu MB, Tang PZ, Liu ZH, Sun BC. Prognostic significance of stomatin-like protein 2 overexpression in laryngeal squamous cell carcinoma: clinical, histologic, and immunohistochemistry analyses with tissue microarray. Hum Pathol. 2007;38:747–52.PubMedCrossRefGoogle Scholar
  13. 13.
    Chang D, Ma K, Gong M, Cui Y, Liu ZH, Zhou XG, et al. SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma. Biomark. 2010;15:104–10. doi: 10.3109/13547500903311910.CrossRefGoogle Scholar
  14. 14.
    Song L, Liu L, Wu Z, Lin C, Dai T, Yu C, et al. Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway. J Pathol. 2012;226:534–43. doi: 10.1002/path.3008.PubMedCrossRefGoogle Scholar
  15. 15.
    Gourgiotis S, Kocher HM, Solaini L, Yarollahi A, Tsiambas E, Salemis NS. Gallbladder cancer. Am J Surg. 2008;196:252–64. doi: 10.1016/j.amjsurg.2007.11.011.PubMedCrossRefGoogle Scholar
  16. 16.
    Balachandran P, Agarwal S, Krishnani N, Pandey CM, Kumar A, Sikora SS, et al. Predictors of long-term survival in patients with gallbladder cancer. J Gastrointest Surg. 2006;10:848–54.PubMedCrossRefGoogle Scholar
  17. 17.
    Varga M, Obrist P, Schneeberger S, Mühlmann G, Felgel-Farnholz C, Fong D, et al. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res. 2004;10:3131–6. doi: 10.1158/1078-0432.CCR-03-0528.PubMedCrossRefGoogle Scholar
  18. 18.
    Malka D, Boige V, Dromain C, Debaere T, Pocard M, Ducreux M. Biliary tract neoplasms: update 2003. Curr Opin Oncol. 2004;16:364–71.PubMedCrossRefGoogle Scholar
  19. 19.
    Wang Y, Cao W, Yu Z, Liu Z. Downregulation of a mitochondria associated protein SLP-2 inhibits tumor cell motility, proliferation and enhances cell sensitivity to chemotherapeutic reagents. Cancer Biol Ther. 2009;8:1651–8.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Wei-Xin Wang
    • 1
  • Qing-Feng Lin
    • 2
  • Dong Shen
    • 2
  • Shao-Ping Liu
    • 2
  • Wei-Dong Mao
    • 2
  • Gui Ma
    • 1
  • Wei-Dong Qi
    • 1
  1. 1.Department of General SurgeryThe Affiliated People’s Hospital of Jiangsu UniversityZhenjiangChina
  2. 2.Department of OncologyAffiliated Jiangyin Hospital of Southeast University Medical CollegeJiangyinChina

Personalised recommendations